BR112019023393A2 - Sistema terapêutico transdérmico contendo escopolamina e polímero híbrido de acrílico e silicone - Google Patents
Sistema terapêutico transdérmico contendo escopolamina e polímero híbrido de acrílico e silicone Download PDFInfo
- Publication number
- BR112019023393A2 BR112019023393A2 BR112019023393-8A BR112019023393A BR112019023393A2 BR 112019023393 A2 BR112019023393 A2 BR 112019023393A2 BR 112019023393 A BR112019023393 A BR 112019023393A BR 112019023393 A2 BR112019023393 A2 BR 112019023393A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic system
- transdermal therapeutic
- scopolamin
- system containing
- silicon polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
a presente invenção refere-se a um sistema terapêutico transdérmico (tts) para administração transdérmica de escopolamina compreendendo uma estrutura em camada contendo escopolamina, a referida estrutura em camada contendo escopolamina composta de: a) uma camada de proteção; e b) uma camada contendo escopolamina; em que o sistema terapêutico transdérmico inclui um polímero híbrido de acrílico e silicone.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17177875.6 | 2017-06-26 | ||
EP17177875 | 2017-06-26 | ||
PCT/EP2018/066955 WO2019002208A1 (en) | 2017-06-26 | 2018-06-25 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING SCOPOLAMINE AND A SILICONE-TYPE ACRYLIC HYBRID POLYMER |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019023393A2 true BR112019023393A2 (pt) | 2020-06-16 |
Family
ID=59312979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019023393-8A BR112019023393A2 (pt) | 2017-06-26 | 2018-06-25 | Sistema terapêutico transdérmico contendo escopolamina e polímero híbrido de acrílico e silicone |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210145760A1 (pt) |
EP (1) | EP3644972A1 (pt) |
JP (1) | JP2020525546A (pt) |
CN (1) | CN110809466A (pt) |
BR (1) | BR112019023393A2 (pt) |
CA (1) | CA3061284A1 (pt) |
WO (1) | WO2019002208A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115989025A (zh) * | 2020-08-31 | 2023-04-18 | 耐贝医药株式会社 | 用于缓解或治疗神经退行性疾病的症状的贴剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19738643C2 (de) * | 1997-09-04 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung |
CA2643037C (en) * | 2006-02-27 | 2014-08-05 | Noven Pharmaceuticals, Inc. | Compositions and methods for delivery of amino-functional drugs |
JP2009540052A (ja) * | 2006-06-06 | 2009-11-19 | ダウ・コーニング・コーポレイション | シリコーンアクリレートハイブリッド組成物およびその製造方法 |
US9017301B2 (en) * | 2007-09-04 | 2015-04-28 | Mylan Technologies, Inc. | Transdermal drug delivery systems comprising a coated release liner |
DE102008048338A1 (de) * | 2008-09-22 | 2010-03-25 | Beiersdorf Ag | Wundversorgungszubereitung mit verminderten Hautirritationen |
CN102803420B (zh) | 2009-04-24 | 2015-06-03 | 汉高知识产权控股有限责任公司 | 基于硅氧烷丙烯酸杂化聚合物的粘合剂 |
JP2013139554A (ja) | 2011-11-29 | 2013-07-18 | Dow Corning Corp | シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法 |
AU2015296807A1 (en) * | 2014-07-31 | 2017-03-09 | Noven Pharmaceuticals, Inc. | Silicone-containing acrylic polymers for transdermal drug delivery compositions |
CN107406554B (zh) * | 2015-02-09 | 2023-04-14 | 美国陶氏有机硅公司 | 多相有机硅丙烯酸类混杂粘弹性组合物及其制备方法 |
-
2018
- 2018-06-25 EP EP18733277.0A patent/EP3644972A1/en not_active Withdrawn
- 2018-06-25 CA CA3061284A patent/CA3061284A1/en active Pending
- 2018-06-25 BR BR112019023393-8A patent/BR112019023393A2/pt not_active Application Discontinuation
- 2018-06-25 CN CN201880040939.7A patent/CN110809466A/zh active Pending
- 2018-06-25 WO PCT/EP2018/066955 patent/WO2019002208A1/en unknown
- 2018-06-25 US US16/623,035 patent/US20210145760A1/en not_active Abandoned
- 2018-06-25 JP JP2020520723A patent/JP2020525546A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN110809466A (zh) | 2020-02-18 |
JP2020525546A (ja) | 2020-08-27 |
EP3644972A1 (en) | 2020-05-06 |
CA3061284A1 (en) | 2019-01-03 |
US20210145760A1 (en) | 2021-05-20 |
WO2019002208A1 (en) | 2019-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017004932A2 (es) | Métodos para seleccionar una línea de células t y donador de la misma para terapia celular adoptiva | |
CR20150664A (es) | Moduladores de los receptores de estrógeno y sus usos | |
CL2016001364A1 (es) | Moduladores de ror gamma (rory) | |
CO2018004132A2 (es) | Polipéptidos del dominio extracelular de cd80 y su uso en el tratamiento del cáncer | |
BR112014019889A8 (pt) | Dispositivos de enxerto resistentes a dobra e sistemas e métodos relacionados | |
MX2019007391A (es) | Sistema terapeutico transdermico que contiene asenapina. | |
AR108021A1 (es) | Conjugados de anticuerpo-principio activo (adcs) de inhibidores de ksp con anticuerpos anti-b7h3 | |
BR112015004704A2 (pt) | sistema de preensão, dispositivo de preensão configurado para prender um artigo médico que tem um corpo alongado, retentor, e dispositivo de preensão configurado para prender um artigo médico que tem um corpo alongado a um paciente | |
BR112013016440A2 (pt) | tira elástica, substrato elástico e método de fixação de uma tira | |
BR112017015158A2 (pt) | composição para proporcionar um filme sobre fibras de queratina | |
BR112015006731A2 (pt) | combinações e usos das mesmas | |
MX2019007389A (es) | Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno. | |
BR112016010205A2 (pt) | ?sistema de vacinação para aplicar vacina para frangas e métodos, dispositivos e montagens associadas?? | |
EA201591196A1 (ru) | Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств | |
AR094289A1 (es) | Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol | |
EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
GT201700194A (es) | Formulación de combinación de tesofensina y betabloqueante | |
BR112019024566A2 (pt) | inibidores de pirazol magl | |
AR109376A1 (es) | FORMULACIONES DE g-HIDROXIBUTIRATO DE LIBERACIÓN MODIFICADA | |
BR112016007410A8 (pt) | conjugados de sn-38 de liberação lenta, formulações farmacêuticas e usos dos conjugados | |
PH12019500949A1 (en) | Ror-gamma modulators | |
MX2020003667A (es) | Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona. | |
BR112018003836A2 (pt) | combinações de inibidor de btk para tratar mieloma múltiplo | |
CL2017002846A1 (es) | Métodos de tratamiento de trastornos linfoproliferativos asociados al virus de epstein-barr por terapia con células t. | |
CY1124303T1 (el) | Διαδερμικο θεραπευτικο συστημα με καλυπτικη ταινια, που περιλαμβανει δυο συγκολλητικα στρωματα |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |